Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo

References

• FanLStrasser-WeipplKLiJJBreast cancer in ChinaLancet Oncol201415279289
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin20156552925559415
   PubMed Web of Science ®Google Scholar
• HarmerVBreast cancer. Part 2: present and future treatment modalitiesBr J Nurs2008171028102919062455
   PubMedGoogle Scholar
• HuangCMWuYTChenSTTargeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosisChem Biol2000745346110903942
   PubMed Web of Science ®Google Scholar
• DugganSTKeatingGMPegylated liposomal doxorubicin a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi’s sarcomaDrugs2011712531255822141391
   PubMed Web of Science ®Google Scholar
• QianYLiuYYanQInhibition of Mus81 by siRNA enhances sensitivity to 5-FU in breast carcinoma cell linesOnco Targets Ther201471883189025364260
   PubMed Web of Science ®Google Scholar
• LuoCWangYChenQAdvances of paclitaxel formulations based on nanosystem delivery technologyMini Rev Med Chem20121243444422303950
   PubMed Web of Science ®Google Scholar
• LuJLiuCWangPThe self-assembling camptothecin-tocopherol prodrug: an effective approach for formulating camptothecinBiomaterials20156217618726057133
   PubMed Web of Science ®Google Scholar
• JiangYZhangYLuanJEffects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of actionCytotechnology20106257358320963488
   PubMed Web of Science ®Google Scholar
• XieCMChanWYYuSZhaoJChengCHBufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activationFree Radic Biol Med2011511365137521763418
   PubMed Web of Science ®Google Scholar
• XieXBYinJQWenLLCritical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: a proteomic-based researchPLoS One20127e4737523091618
   PubMed Web of Science ®Google Scholar
• YinPHLiuXQiuYYAnti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patientsAsian Pac J Cancer Prev2012135339534323317181
   PubMedGoogle Scholar
• QiuDZZhangZJWuWZYangYKBufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cellsBMC Complement Altern Med20131318519523870199
   PubMed Web of Science ®Google Scholar
• LiMYYuXJGuoHBufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cellsTumour Biol2014352461247124218335
   PubMedGoogle Scholar
• QiuYYHuQTangQFMicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasisTumour Biol2014352599260624375248
   PubMed Web of Science ®Google Scholar
• YangZTengYWangHHouHEnhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluationInt J Pharm201344723124023467076
   PubMed Web of Science ®Google Scholar
• HuQLiangBSunYPreparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancerInt J Nanomedicine201494035404125187707
   PubMed Web of Science ®Google Scholar
• MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancsCancer Res198646638763922946403
   PubMed Web of Science ®Google Scholar
• MaedaHSeymourLWMiyamotoYConjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivoBioconjug Chem199233513621420435
   PubMed Web of Science ®Google Scholar
• MaedaHSMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapyAdv Drug Deliv Rev20014616918511259839
   PubMed Web of Science ®Google Scholar
• MaedaHSawaTKonnoTMechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCSJ Control Release200174476111489482
   PubMed Web of Science ®Google Scholar
• MaedaHBharateGYDaruwallaJPolymeric drugs for efficient tumor-targeted drug delivery based on EPR-effectEur J Pharm Biopharm20097140941919070661
   PubMed Web of Science ®Google Scholar
• DozonoHYanazumeSNakamuraHHPMA copolymer- conjugated pirarubicin in multimodal treatment of a patient with stage IV prostate cancer and extensive lung and bone metastasesTarget Oncol20161110110626194363
   PubMed Web of Science ®Google Scholar
• FleigeEQuadirMAHaagRStimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applicationsAdv Drug Deliv Rev20126486688422349241
   PubMed Web of Science ®Google Scholar
• RenTXiaWWuWLiYStimuli-responsive and polymeric prodrugsProg Chem201325775784
   Web of Science ®Google Scholar
• OerlemansCBultWBosMStormGNijsenJFHenninkWEPolymeric micelles in anticancer therapy: targeting, imaging and triggered releasePharm Res2010272569258920725771
   PubMed Web of Science ®Google Scholar
• CabralHKataokaKProgress of drug-loaded polymeric micelles into clinical studiesJ Control Release201419046547624993430
   PubMed Web of Science ®Google Scholar
• ZhangYZhangHWangXWangJZhangXZhangQThe eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micellesBiomaterials20123367969122019123
   PubMed Web of Science ®Google Scholar
• VirgoliniILeimerMHandmakerHSomatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, Tc-99-m-P829Cancer Res199858185018599581824
   PubMed Web of Science ®Google Scholar
• CorletoVDNasoniSPanzutoFCassettaSDelle FaveGSomatostatin receptor subtypes: basic pharmacology and tissue distributionDig Liver Dis200436S8S1615077906
   PubMedGoogle Scholar
• WattHLKumarUColocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cellsCancer Cell Int2006611916436212
   PubMed Web of Science ®Google Scholar
• BrunsCWeckbeckerGRaulfFMolecular pharmacology of somatostatin-receptor subtypesAnn N Y Acad Sci19947331381467978861
   PubMed Web of Science ®Google Scholar
• PatelYCSrikantCBSubtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1–5)Endocrinology1994135281428177988476
   PubMed Web of Science ®Google Scholar
• SiehlerSSeuwenKHoyerD[125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptorsEur J Pharmacol19983483113209652348
   PubMed Web of Science ®Google Scholar
• HashemiSHBenjegårdSAAhlmanH111In-labelled octreotide binding by the somatostatin receptor subtype 2 in neuroendocrine tumoursBr J Surg20039054955412734860
   PubMed Web of Science ®Google Scholar
• HuoMRZouAYaoCSomatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micellesBiomaterials2012336393640722704599
   PubMed Web of Science ®Google Scholar
• ZhangJJinWWangXWangJZhangXZhangQA novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor modelsMol Pharm201071159116820524673
   PubMed Web of Science ®Google Scholar
• ZhangYWangXWangJZhangXZhangQOctreotide-modified polymeric micelles as potential carriers for targeted docetaxel delivery to somatostatin receptor overexpressing tumor cellsPharm Res2011281167117821340573
   PubMed Web of Science ®Google Scholar
• LiuJZahediPZengFAllenCNano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxelJ Pharm Sci2008973274329018064681
   PubMed Web of Science ®Google Scholar
• ShenYJinEZhangBProdrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug deliveryJ Am Chem Soc20101324259426520218672
   PubMed Web of Science ®Google Scholar
• ZhangGZhangMHeJNiPSynthesis and characterization of a new multifunctional polymeric prodrug paclitaxel-polyphosphoester-folic acid for targeted drug deliveryPolym Chem2013445154525
   Web of Science ®Google Scholar
• DongCXiaWLiYRenTSelf-assembled, redox-sensitive, H-shaped pegylated methotrexate conjugates with high drug-carrying capability for intracellular drug deliveryMedChemComm20145147152
   Web of Science ®Google Scholar
• WangWLiCZhangJTailor-made gemcitabine prodrug nanoparticles from well-defined drug-polymer amphiphiles prepared by controlled living radical polymerization for cancer chemotherapyJ Mater Chem B2014218911901
   Web of Science ®Google Scholar
• ZouJZhangFZhangSPoly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel deliveryAdv Healthc Mater2014344144823997013
   PubMed Web of Science ®Google Scholar
• HuoMZhuQWuQSomatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapyJ Pharm Sci20151042018202825820241
   PubMed Web of Science ®Google Scholar
• AnZTangWWuMJiaoZStuckyGDHeterofunctional polymers and core-shell nanoparticles via cascade aminolysis/Michael addition and alkyne-azide click reaction of RAFT polymersChem Commun (Camb)2008486501650319057759
   PubMedGoogle Scholar
• LiuTQianYHuXMixed polymeric micelles as multifunctional scaffold for combined magnetic resonance imaging contrast enhancement and targeted chemotherapeutic drug deliveryJ Mater Chem20122250205030
   Web of Science ®Google Scholar